The prevalence of nutritional disorders has increased in children and adolescents in developed and developing countries, indicating deficiencies of essential vitamins and minerals ([@CIT0001], [@CIT0002]). This prevalence has resulted in a significant impairment of growth and development in this population ([@CIT0003]).

Nutritional assessments are important for monitoring the health and nutritional status of children. Among the many nutritional assessment methods, anthropometry and body composition provide acceptable accuracy with similar discriminative ability when measured by dual-energy X-ray absorptiometry ([@CIT0004], [@CIT0005]).

Methods that accurately assess body composition in children are scarce. International body mass index (BMI)-for-age cutoffs have been proposed to classify overweight and underweight children ([@CIT0006], [@CIT0007]). However, BMI levels among children should be interpreted with caution. Although a high BMI-for-age is a good indicator of excess fat mass (FM), BMI cannot differentiate whether the weight change is due to variations of FM, fat-free mass (FFM), or water ([@CIT0008], [@CIT0009]).

Bioelectrical impedance (BIA) is a user-friendly, non-invasive, low-cost, portable method that can be used to calculate the total body fat in children and adults, and it is considered to be a useful tool for assessing body composition ([@CIT0010]--[@CIT0013]). However, when using conventional BIA, it is difficult to establish the effect of body weight in prediction equations, and no single equation has been developed to calculate the total body fat in children of different ages. Therefore, an accurate evaluation using the bioelectrical impedance vector analysis (BIVA) is necessary, and the patterns are based only on the electrical properties of the tissues. Combined changes in tissue hydration (resistance component) and structure (reactance component) can be monitored with BIVA. Both components of the impedance vector are considered simultaneously, and body composition can be interpreted ([@CIT0014]). The graphical method of resistance and reactance corrected by body length (RXc) is based on analysis of the bivariate impedance vector distribution in a healthy population with specific features ([@CIT0010]).

BIVA is a qualitative method and does not provide quantitative measurements of corporal volumes ([@CIT0015]--[@CIT0018]). BIVA is useful for clinical purposes because of its ability to detect changes in hydration or body composition in children ([@CIT0009]). Therefore, BIVA may be helpful in identifying those children who are at risk of pathological changes in body composition, specifically during chronic conditions (i.e. chronic obstructive pulmonary disease, anorexia nervosa, cancer, and chronic renal failure) ([@CIT0014], [@CIT0019]--[@CIT0024]).

Supplementary zinc exerts a positive effect on nutritional status through positive weight gain ([@CIT0025]). Moreover, zinc is an essential nutrient required for numerous metabolic functions, and its deficiency results in growth retardation, cell-mediated immune dysfunction and cognitive impairment, and decreased protein and nucleic acid synthesis ([@CIT0026]).

This study used a BIA vector to evaluate nutritional status in prepubertal healthy and eutrophic children supplemented with zinc to detect changes in body composition status.

Methods {#S0002}
=======

Subjects {#S0002-S20001}
--------

The participants included 60 healthy and eutrophic prepubertal children aged between 8 and 9 years from three municipal schools in the city of Natal, Brazil. Informed consent was obtained from all of the children and their parents or guardians before data collection. This study was approved by the Onofre Lopes University Hospital Research Ethics Committee of Federal University of Rio Grande do Norte (UFRN) (protocol number 542/11). The subjects were recruited through an advertisement on school noticeboards and meetings with parents. The children were divided into control and experimental groups, and the pairing was performed randomly. The parents and children did not know the status of their experimental group (EG; or oral solution). Only one member of the team controlled the experiments and revealed children\'s experimental status (control or experimental group) at the time of data collection.

Inclusion and exclusion criteria {#S0002-S20002}
--------------------------------

The children were healthy, eutrophic, and at Tanner stage 1 for genital, breast, and pubic hair growth, which was evaluated by a medical doctor. The exclusion criteria were missing or incomplete dietary data; early pubarche, thelarche, or menarche; nutritional disorders; history of disease (neoplasia; diabetes mellitus; liver, kidney, and thyroid disorders; and acute infectious or inflammatory diseases); undergoing surgery; using vitamin or mineral supplements; and children outside the interval −2 to 2+*Z*-score for sex-specific BMI-for-age, weight-for-age, and height-for-age indices, according to the 2006 World Health Organization curves ([@CIT0027]).

Experimental design {#S0002-S20003}
-------------------

This study was a randomized, controlled, triple-blind study and was based on non-probability sampling (convenience sample). The control group (CG) (*n*=29) was supplemented with placebo (10% sorbitol, the same vehicle used to prepare zinc solution) and the EG (*n*=31) was supplemented daily with 10 mg of elemental zinc for 3 months. The CG consisted of 16 males and 13 females, and the EG consisted of 16 males and 15 females. All children underwent anthropometry, BIA measurements, and blood collection to analyze serum zinc at the beginning and end of this study.

Anthropometry {#S0002-S20004}
-------------

Anthropometric measurements were performed after an overnight fast. Weight (kg) and height (m) were measured using an electronic balance (Balmak, BK50F, São Paulo, SP, Brazil) and a stadiometer (Stadiometer Professional Sanny, American Medical do Brasil, São Paulo, SP, Brazil), respectively. To measure weight, the child stood on the scale wearing light clothing without shoes. To measure height, the child remained standing without shoes with free head props, heels together, arms extended along the body, and an upright body posture. The heels, buttocks, shoulders, and head touched the wall or vertical surface of the measuring equipment. All measurements were performed by the same examiner to avoid bias ([@CIT0028]). New growth curves provided by the World Health Organization for children aged 5 to 19 years were used to classify malnutrition, eutrophic state, and obesity ([@CIT0029]). BMI was calculated as the ratio between the body weight (kg) and the square of height in meters (kg/m^2^). BMI was evaluated by the AnthroPlus v1.0.4 program (available at [www.who.int/growthref/en/](http://www.who.int/growthref/en/)).

Bioelectrical measurements {#S0002-S20005}
--------------------------

Bioimpedance (BIA) is a nutritional assessment method that estimates body composition and therefore nutritional status. Resistance (*R*) and Reactance (*Xc*) are the components of this method that will provide this information. After the child had emptied his/her bladder, BIA was performed with a BIA analyzer (Quantum II, RJL Systems, Comp Corp., Clinton Township, MI, USA). The Houtkooper equation ([@CIT0030]) ([Table 1](#T0001){ref-type="table"}), which was validated and currently recommended for use in children, was utilized ([@CIT0031]). This technique requires the precise placement of four electrodes (standard tetrapolar placement on the right hand and foot) strictly following the method reported by Lukaski et al. ([@CIT0032]). The two components of the whole-body impedance vector were recorded from single representative stable measurements conducted by the same operator.

###### 

Results of body composition obtained in the control (CG, *n*=29) and experimental (EG, *n*=31) groups before and after placebo or oral zinc supplementation in prepubertal and healthy children

                          CG-before vs. CG-after   CG-before vs. EG-before   CG-before vs. EG-after   CG-after vs. EG-before   CG-after vs. EG-after   EG-before vs. EG-after
  ----------------------- ------------------------ ------------------------- ------------------------ ------------------------ ----------------------- ------------------------
  BMI-for-age (kg/m^2^)                                                                                                                                
  Mean difference         −0.1966                  −0.08854                  −0.4982                  0.1080                   −0.3017                 −0.4097
  95% CI of difference    −1.444 to 1.051          −1.316 to 1.139           −1.726 to 0.729          −1.119 to 1.335          −1.529 to 0.925         −1.617 to 0.797
  Significance            NS                       NS                        NS                       NS                       NS                      *p*=0.005
  *R/H* (Ohm/m)                                                                                                                                        
  Mean difference         −1.098                   1.905                     10.30                    3.002                    11.40                   8.398
  95% CI of difference    −53.10 to 50.90          −49.25 to 53.06           −40.85 to 61.45          −48.15 to 54.15          −39.75 to 62.55         −41.89 to 58.69
  Significance            NS                       NS                        NS                       NS                       NS                      NS
  *Xc/H* (Ohm/m)                                                                                                                                       
  Mean difference         −0.5828                  1.163                     0.7157                   1.746                    1.298                   −0.4474
  95% CI of difference    −5.614 to 4.448          −3.786 to 6.112           −4.234 to 5.665          −3.203 to 6.695          −3.651 to 6.248         −5.313 to 4.419
  Significance            NS                       NS                        NS                       NS                       NS                      NS

BMI, body mass index; *R*, resistance; *H*, height; *Xc*, reactance. NS, not significant (*p*\>0.05) and significant (*p*=0.005), using Tukey\'s multiple comparisons test.

Resistance (R) {#S0002-S20006}
--------------

The *R* is the opposition to flow of an alternating current through intra- and extracellular ionic solutions representing the real portion of the impedance (*Z*). Lean tissues are excellent conductors of electric current due to the large amount of water and electrolytes, that is, they have low *R* to the passage of electric current. On the contrary, fat, bone, and skin constitute a means of low conductivity, and therefore have high *R*.

Reactance (Xc) {#S0002-S20007}
--------------

The *Xc* is the capacitance produced by tissue interfaces and cell membranes representing the imaginary portion of the *Z* across tissues ([@CIT0033]). *Xc* means the opposition to an electric current caused by the capacitance (property of storing energy in the form of an electrostatic field). The combination of these two values provides information about total body water, FFM, and FM.

BIVA {#S0002-S20008}
----

The BIVA plots direct measurements of the vectors *R* and *Xc* from the impedance analyzer (RXc graph). According to the RXc graph, impedance measurements standardized by the height of the subject are represented as bivariate vectors with their confidence and tolerance intervals, which are ellipses in the RXc plane. These vectors do not depend on equations ([@CIT0034]). The BIVA according to the RXc method is a good indicator of clinical outcomes and for clinical research studies aiming to identify disorders in body composition ([@CIT0035], [@CIT0036]). To investigate the differences between groups, we calculated and plotted the 95% confidence intervals for the average bivariate vector impedance for each group. Furthermore, we calculated and plotted the tolerance ranges of 95, 75, and 50% for the children, which were divided according to the group and time of the study. Healthy Italian children were used as a reference population to compare bioelectrical data ([@CIT0036]).

Oral zinc supplementation {#S0002-S20009}
-------------------------

The EG was supplemented with 10 mg Zn per day for 3 months in the form of zinc sulfate heptahydrate (ZnSO~4~·7H~2~O; Merck, Darmstadt, Germany). Oral zinc solution (152.97 µmol Zn/day) was prepared at the Pharmacotechnical Laboratory of the Department of Pharmacy, UFRN. Each drop contained 1 mg of elemental zinc. The CG received an oral placebo as sorbitol 10%. These solutions were added to milk or juice every morning at breakfast. Zinc supplementation was monitored every 2 weeks during home visits by the same observer.

Materials {#S0002-S20010}
---------

Vacuette Z serum clot activator tubes (Greiner Bio-One, Monroe, NC, USA) were used for biochemical analyses. Becton Dickinson tubes (Trace Element, Serum, Franklin Lakes, NJ, USA) were used for zinc analyses. Polypropylene plastic syringes were purchased from BD (Hercules, CA, USA), and plastic tips and tubes (metal-free) were purchased from BioRad Laboratories (Hercules, CA, USA). Zinc sulfate heptahydrate (ZnSO~4~·7H~2~O) and Titrisol zinc standard were purchased from Merck (Darmstadt, Germany).

Laboratory procedures {#S0002-S20011}
---------------------

All blood samples were collected into the appropriate tubes, and the procedures related to the handling of zinc samples were performed in accordance with international standards ([@CIT0037]). After sample collection, the laboratory procedures were performed at the Multidisciplinary Laboratory of Chronic Degenerative Diseases. The blood samples were placed in trace metal-free tubes without anticoagulants and remained in a stainless steel incubator (FANEM 502, São Paulo, SP, Brazil) for 120 min until clot formation occurred. A 500 mL volume of serum was collected with plastic, trace-metal-free pipettes and was transferred to plastic tubes containing 2,000 μL ultra-pure water (Milli-Q Plus, Millipore, Billerica, MA, USA) to dilute the serum (1:4) for zinc analyses. The samples were stored at −80°C for subsequent analyses (Ultralow Freezer, Nuaire, MN, USA). The serum zinc samples were analyzed in triplicates within the same assay by atomic absorption spectrophotometry (SpectrAA-240FS, Varian, Mulgrave, Victoria, Australia) according to the manufacturer\'s instructions. Zinc sensitivity was 0.01 μg/mL. The intra-assay coefficient of variation was 2.37%. The normal reference range was 0.7--1.2 μg/mL. A standard zinc solution (1,000 mg/mL) was obtained by diluting a Titrisol zinc standard in ultra-pure water. The wavelength was 213.9 nm. The lamp current was 10 mA, and all other procedures, such as calibrations and measurements, were performed according to the manufacturer\'s instructions.

Statistical analyses {#S0002-S20012}
--------------------

The D\'Agostino--Pearson omnibus normality test was used to analyze the normality of all study data. Paired Student\'s *t*-test was used to compare the data obtained in the control and experimental groups. The Wilcoxon matched-pairs signed rank test was used to complement the paired, non-parametric test. All comparisons were considered to be significant at the 5% significance level. All analyses and figures were performed and created with the GraphPad Prism 6.0 software (GraphPad Software, Inc., San Diego, CA, USA). The BIVA statistical analyses were performed using BIVA software 2003. To determine the group differences, the bivariate 95% confidence interval for the mean impedance vector was calculated and plotted using the bivariate normal distribution of *R* divided by height (*R/H*) and Xc divided by height (*Xc/H*). The unpaired, two-sample Hotelling\'s *T* ^2^ test for vector analysis was performed. Separate 95% confidence ellipses indicated a significant difference between the mean vector positions on the RXc plane (equivalent to a significant two-sample Hotelling\'s *T* ^2^ test, *p*\<0.05). The paired, one-sample Hotelling\'s *T* ^2^ test was performed to determine if the changes in the mean group vectors (measured at the first and second time points) were significantly different from zero (null vector). A 95% confidence ellipse excluding the null vector indicated a significant vector displacement ([@CIT0031]). These tests are a multivariate extension of Student\'s *t*-test. To determine whether the results were true for the population studied, we used a sample size calculation for the comparison of two means (paired samples) as follows: *n*=(*Zα+Zβ*)^2^.*σ*^2^~D~/*δ*^2^, where *α*=0.05, *P* (test power)=0.90, *β*=2(1−*P*)=0.20, *σ*^2^D (standard deviation of the difference)=0.105043, and *δ*\>−0.09 (maximum permissible difference).

Results {#S0003}
=======

This study was conducted with 29 children in the CG and 31 children in the EG who underwent anthropometric and bioelectrical assessments. The sample size (60 children) was adequate for the conclusions in this study. For any value, *δ*≥−0.09 (i.e. the minimum sample size required was 15 patients). According to the BMI-for-age classification, all children were healthy during the 3-month study ([Table 1](#T0001){ref-type="table"}).

Assuming a bivariate normal distribution of *R/H* and *Xc/H*, we calculated the bivariate 95% confidence limits for the mean impedance vectors of the different classification groups (i.e. the ellipse within the two-dimensional mean vector falls with a 95% probability). The 'RXc mean graph' was the average of *R/H* and *Xc/H* recorded the groups ([@CIT0038]).

The mean vectors for the CG and EG were plotted before and after placebo and supplementation. The 95% confidence ellipses of the three mean vectors of each group overlapped, which indicates that the position between the vectors at the CG, EG, and reference population (healthy Italian children) were not significantly different in the RXc plane. The paired one-sample Hotelling\'s *T* ^2^ test indicated a difference in the mean vectors between the first measurement (before placebo or supplementation) and the second measurement (after placebo or supplementation). The EG had increased in the soft tissue (primarily FFM) body composition after oral zinc supplementation compared with before supplementation (*p*\<0.0001). However, the *p* value of the paired one-sample Hotelling\'s *T* ^2^ test for the CG was 0.9 ([Fig. 1](#F0001){ref-type="fig"}).

![The 95% confidence ellipses of impedance vectors measured by the difference between before and after placebo (control group) and before and after zinc supplementation (experimental group).](FNR-59-28918-g001){#F0001}

We drew bivariate 50, 75, and 95% tolerance intervals of the impedance vector in the reference population. We then plotted the distribution of individual vectors on the reference ellipses, which allowed for the comparison of the bivariate, intersubject impedance variability. These ellipses were separated by groups before and after placebo or zinc supplementation versus the reference population (healthy Italian children) ([Fig. 2](#F0002){ref-type="fig"}).

![Distribution of impedance vectors with the 50, 75, and 95% tolerance ellipses for (A) the control group before placebo, (B) the control group after placebo, (C) the experimental group before zinc supplementation, and (D) the experimental group after zinc supplementation. R/H, resistance/length; Xc/H, reactance/length.](FNR-59-28918-g002){#F0002}

The distribution of individual vectors reflected the heterogeneity of hydration status in eutrophic children ranging from severe dehydration (vectors beyond the upper pole of the 95% tolerance ellipse) to pre-edema fluid overload (vectors close to the lower pole of the 75% tolerance ellipse) in both groups. The CG demonstrated a tendency for dehydration and decreased soft tissue. The EG demonstrated a tendency for increased soft tissue (primarily the FFM).

The serum zinc levels were not significantly different between the groups ([Fig. 3](#F0003){ref-type="fig"}). However, zinc intake plus zinc supplementation was significantly different in the EG when compared with a CG (*p*\<0.0001). Moreover, the tolerable upper zinc intake level did not exceed the expected values of 23 mg Zn per day for children in the EG. There were no side effects associated with the 10 mg Zn per day.

![Serum zinc levels in the control group before placebo (CG-B) and after placebo (CG-A) and in the experimental group before zinc supplementation (EG-B) and after zinc supplementation (EG-A).](FNR-59-28918-g003){#F0003}

Discussion {#S0004}
==========

In this study on 60 healthy and eutrophic children, we compared the effect of zinc supplementation on nutritional status as evaluated by BIVA for assessing body composition. We obtained the tolerance intervals of ellipses in children aged between 8 and 9 years. BIVA is a clinically useful method and can be used for routine monitoring of variations in body fluids and nutritional status in children.

The length of the vector indicates hydration status, and a left/right shift of the vector indicates soft tissue mass ([@CIT0035]). In clinical validation studies in adults, vectors falling out of the 75% tolerance ellipse indicate abnormal tissue impedance. An upper pole or lower pole displacement of the vectors parallel to the major axis of tolerance ellipses indicates tissue dehydration or hyper-hydration, respectively. Extremes of soft tissue mass, such as in obese people and athletes, or lean and wasting conditions are associated with a vector displacement to the left or to the right, respectively, along the minor axis of tolerance ellipses ([@CIT0036], [@CIT0037], [@CIT0039]).

To date, longitudinal data regarding the use of BIA vector for evaluating children after zinc supplementation have not been reported in the literature. We found positive changes in the body composition with zinc supplementation. BIVA in healthy neonates provides good results for obtaining nutritional status and body fluids, and their clinical state could be predicted depending on their location within the quadrants of the graphic ellipses ([@CIT0038]). BIVA has been used for detection, monitoring, and controlling hydration and nutritional status using vector displacement for feedback among patients with Alzheimer\'s disease ([@CIT0040]), cachexia ([@CIT0041]), stable and non-stable heart failure patients ([@CIT0042]), critically ill and cardiorenal patients ([@CIT0043]), hemodialysis patients ([@CIT0044]), and cancer patients ([@CIT0028], [@CIT0045]). However, there are no references in the literature regarding zinc intervention and BIVA to compare with our study. Therefore, we did not have a reference method or gold standard for the estimation of body composition, and the results should be interpreted with caution.

Concerning anthropometric assessment, the BMI-for-age increased after oral zinc supplementation in the EG. This physiological effect is expected, even in healthy children ([@CIT0046]). All children were classified as eutrophic throughout the study using the BMI-for-age. Some studies have demonstrated that BIVA has an advantage compared with other methods because BIVA is a good identifier of individual vectors indicating changes in tissue hydration and body structure in subjects from any BMI class. Guida et al. ([@CIT0009]) reported a BMI-specific difference in vector position in an 8-year-old age group with progressive vector shortening in groups with increasing BMI class. We used BIVA to observe whether there were changes in body composition with oral zinc supplementation. We suggest that this supplementation changed the body composition of children because the *p* value in the EG was\<0.0001 (calculated by the BIVA software).

Limitations {#S0004-S20001}
-----------

The main limitation of this study was its relatively small sample size. Nevertheless, the rate of compliance was satisfactory. As our sample was not probabilistic, other studies with a more representative population are required. Moreover, this was an innovative study that used a novel methodological approach, and there were no previous references in the scientific literature using BIVA to assess a nutritional intervention.

Conclusions {#S0005}
===========

Following the analyses of ellipses by BIVA, we found that this method may detect improvements in body composition (primarily the FFM) in healthy children supplemented with zinc. This finding suggests that BIVA can be used to study a small population undergoing zinc (or other micronutrients) intervention. However, longitudinal data are required to investigate vector migration during zinc supplementation. Monitoring the vector displacement trajectory toward the reference target vector position may represent useful feedback during nutritional therapy. Other studies are required to confirm our results. Currently, BIVA is still not considered to be a gold standard.
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